Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
2023年9月4日 - 9:06PM
Report of transactions of shares and related securities of Bavarian
Nordic by persons holding managerial responsibilities and/or
persons/companies closely associated with such
COPENHAGEN, Denmark, September 4,
2023 – Bavarian Nordic A/S (OMX: BAVA) has today received
information about the following transactions of the company’s
shares/related securities by persons holding managerial
responsibilities and/or persons/companies closely associated with
such.
1. |
Details of the person discharging managerial
responsibilities/person closely associated |
a) |
Name |
Luc Debruyne |
2. |
Reason for the notification |
a) |
Position/status |
Chairman of the Board of Directors of Bavarian Nordic A/S |
b) |
Initial notification/Amendment |
Initial notification |
3. |
Details of the issuer, emission allowance market
participant, auction platform, auctioneer or auction
monitor |
a) |
Name |
Bavarian Nordic A/S |
b) |
LEI |
2138006JCDVYIN6INP51 |
4. |
Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted |
a) |
Description of the financial instrument, type of instrument
Identification code |
Shares DK0015998017 |
b) |
Nature of the transaction |
Purchase |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
DKK 154.69 |
4,800 |
d) |
Aggregated information
|
4,800 DKK 742,490.88 |
e) |
Date of the transaction |
2023-09-04 |
f) |
Place of the transaction |
Nasdaq Copenhagen A/S, XCSE |
About Bavarian NordicBavarian
Nordic is a fully integrated vaccines company focused on the
research and development, manufacturing and commercialization of
life-saving vaccines. We are a global leader in smallpox and mpox
vaccines, which have been developed through our long-standing
partnership with the U.S. Government to enhance public health
preparedness and have a strong portfolio of vaccines for travelers
and endemic diseases. For more information visit
www.bavarian-nordic.com.
ContactsEurope: Rolf Sass
Sørensen, Vice President Investor Relations, Tel: +45 61 77 47
43US: Graham Morrell, Paddock Circle Advisors,
graham@paddockcircle.com, Tel: +1 781 686 9600
Company Announcement no. 34 / 2023
Bavarian Nordic AS (TG:BV3)
過去 株価チャート
から 5 2024 まで 6 2024
Bavarian Nordic AS (TG:BV3)
過去 株価チャート
から 6 2023 まで 6 2024